Tag Archives: EndoChoice

EndoChoice Receives FDA Clearance for Lumos™ with Adaptive Matrix Imaging

Image Enhancement Software Shows Promise As Detection Aid During GI Procedures ALPHARETTA, Ga., Aug. 3, 2016 /PRNewswire/ — EndoChoice Holdings, Inc. (NYSE: GI) announced the recent FDA clearance and US launch of Lumos™ with Adaptive Matrix Imaging. This novel and proprietary imaging software system will now be part of the Company’s Generation 3 Fuse® Full Spectrum Endoscopy® System. EndoChoice scientists ...

Read More »

EndoChoice (GI) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of EndoChoice Holdings, Inc.; Encourages Investors To Contact The Firm for Information Concerning Their Legal Rights

SAN DIEGO, Aug. 6, 2016 /PRNewswire/ — Johnson & Weaver, LLP, based in San Diego California with offices in New York, New York, and Marietta, Georgia, is investigating potential violations of the federal securities laws by EndoChoice Holdings, Inc. (NYSE: GI) and certain of its officers and directors. EndoChoice is a medical device company based in Alpharetta, Georgia. Specifically, Johnson ...

Read More »